Reducing the prescription of antibiotics in newborn infants, suspected for an early onset sepsis.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22612

Enrollment

900

Registered

2008-03-26

Start date

2008-01-03

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early onset sepsis Neonatal sepsis Cytokines Antibiotics Vroege infectie Neonatale infectie Cytokinen Antibiotica

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: 1. A newborn infant who is admitted to a pediatric or to a maternity ward and in whom an EOS cannot be excluded. 2. Informed consent of the parent or legal guardian.

Exclusion criteria

Exclusion criteria: 1. Newborn infant older than 6 hours.

Design outcomes

Secondary

Measure	Time frame
Secondary outcome: 1. Proven EOS, 2. Clinical EOS, 3. Suspected EOS but afterwards no EOS, 4. No EOS and never suspected for an EOS.	—

Primary

Measure	Time frame
proven EOS vs. no EOS EOS is defined as a positive blood culture taken within 48 hours after birth. Cultures positive for organisms considered as contaminants (such as corynebacterium) are excluded.	—

Contacts

Public ContactPaul Broek, van den

Universitair Medisch Centrum Groningen Hanzeplein 1

p.van.den.broek@bkk.umcg.nl+31 (0)50 3611506

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)